Regulation of platelet functions by P2 receptors

被引:219
作者
Gachet, C [1 ]
机构
[1] Etab Francais Sang Alsace, INSERM, Unite 311, F-67065 Strasbourg, France
关键词
hemostasis; thrombosis; ADP; P2Y(1); P2Y(12); P2X(1);
D O I
10.1146/annurev.pharmtox.46.120604.141207
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The main role of blood platelets is to ensure primary hemostasis, which is the maintenance of vessel integrity and cessation of bleeding upon injury. While playing a major part in acute arterial thrombosis, platelets are also involved in inflammation, atherosclerosis, and angiogenesis. ADP and ATP play a crucial role in platelet activation, and their receptors are potential targets for antithrombotic drugs. The ATP-gated cation channel P2X(1) and the two G protein-coupled ADP receptors, P2Y(1) and P2Y(12), selectively contribute to platelet aggregation and formation of a thrombus. Owing to its central role in the growth and stabilization of a thrombus, the P2Y(12) receptor is an established target of antithrombotic drugs such as clopidogrel. Studies in P2Y(1) and P2X(1) knockout mice and selective P2Y(1) and P2X(1) antagonists have shown that these receptors are also attractive targets for new antithrombotic compounds. The potential role of platelet P-2 receptors in the involvement of platelets in inflammatory processes is also discussed.
引用
收藏
页码:277 / 300
页数:26
相关论文
共 149 条
  • [1] Characterization of the UDP-glucose receptor (re-named here the P2Y14 receptor) adds diversity to the P2Y receptor family
    Abbracchio, MP
    Boeynaems, JM
    Barnard, EA
    Boyer, JL
    Kennedy, C
    Miras-Portugal, MT
    King, BF
    Gachet, C
    Jacobson, KA
    Weisman, GA
    Burnstock, G
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2003, 24 (02) : 52 - 55
  • [2] Flow cytometric analysis of intraplatelet VASP phosphorylation for the detection of clopidogrel resistance in patients with ischemic cardiovascular diseases
    Aleil, B
    Ravanat, C
    Cazenave, JP
    Rochoux, G
    Heitz, A
    Gachet, C
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2005, 3 (01) : 85 - 92
  • [3] P-selectin in haemostasis
    André, P
    [J]. BRITISH JOURNAL OF HAEMATOLOGY, 2004, 126 (03) : 298 - 306
  • [4] Resistance to thienopyridines: Clinical detection of coronary stent thrombosis by monitoring of vasodilator-stimulated phosphoprotein phosphorylation
    Barragan, P
    Bouvier, JL
    Roquebert, PO
    Macaluso, G
    Commeau, P
    Comet, B
    Lafont, A
    Camoin, L
    Walter, U
    Eigenthaler, M
    [J]. CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2003, 59 (03) : 295 - 302
  • [5] Baurand A, 2000, THROMB HAEMOSTASIS, V84, P484
  • [6] Differential regulation and relocalization of the platelet P2Y receptors after activation:: A way to avoid loss of hemostatic properties?
    Baurand, A
    Eckly, A
    Hechler, B
    Kauffenstein, G
    Galzi, JL
    Cazenave, JP
    Léon, C
    Gachet, C
    [J]. MOLECULAR PHARMACOLOGY, 2005, 67 (03) : 721 - 733
  • [7] Inhibition of platelet function by administration of MRS2179, a P2Y1 receptor antagonist
    Baurand, A
    Raboisson, P
    Freund, M
    Léon, C
    Cazenave, JP
    Bourguignon, JJ
    Gachet, C
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 2001, 412 (03) : 213 - 221
  • [8] Scientific and therapeutic advances in antiplatelet therapy
    Bhatt, DL
    Topol, EJ
    [J]. NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (01) : 15 - 28
  • [9] Purification and functional reconstitution of the human P2Y12 receptor
    Bodor, ET
    Waldo, GL
    Hooks, SB
    Corbitt, J
    Boyer, JL
    Harden, TK
    [J]. MOLECULAR PHARMACOLOGY, 2003, 64 (05) : 1210 - 1216
  • [10] ADENOSINE-DIPHOSPHATE AS A MEDIATOR OF PLATELET-AGGREGATION INVIVO - AN EDITORIAL VIEW
    BORN, GVR
    [J]. CIRCULATION, 1985, 72 (04) : 741 - 746